Apoptosis and necroptosis induced by stenodactylin in neuroblastoma cells can be completely prevented through caspase inhibition plus catalase or necrostatin-1

Phytomedicine. 2016 Jan 15;23(1):32-41. doi: 10.1016/j.phymed.2015.11.006. Epub 2015 Dec 6.

Abstract

Background: Stenodactylin is a highly toxic plant lectin purified from the caudex of Adenia stenodactyla, with molecular structure, intracellular routing and enzyme activity similar to those of ricin, a well-known type 2 ribosome-inactivating protein. However, in contrast with ricin, stenodactylin is retrogradely transported not only in peripheral nerves but also in the central nervous system.

Purpose: Stenodactylin properties make it a potential candidate for application in neurobiology and in experimental therapies against cancer. Thus, it is necessary to better clarify the toxic activity of this compound.

Study design: We investigated the mechanism of stenodactylin-induced cell death in the neuroblastoma-derived cell line, NB100, evaluating the implications of different death pathways and the involvement of oxidative stress.

Methods: Stenodactylin cytotoxicity was determined by evaluating protein synthesis and other viability parameters. Cell death pathways and oxidative stress were analysed through flow cytometry and microscopy. Inhibitors of apoptosis, oxidative stress and necroptosis were tested to evaluate their protective effect against stenodactylin cytotoxicity.

Results: Stenodactylin efficiently blocked protein synthesis and reduced the viability of neuroblastoma cells at an extremely low concentration and over a short time (1 pM, 24 h). Stenodactylin induced the strong and rapid activation of apoptosis and the production of free radicals. Here, for the first time, a complete and long lasting protection from the lethal effect induced by a toxic type 2 ribosome-inactivating protein has been obtained by combining the caspase inhibitor Z-VAD-fmk, to either the hydrogen peroxide scavenger catalase or the necroptotic inhibitor necrostatin-1.

Conclusion: In respect to stenodactylin cytotoxicity, our results: (i) confirm the high toxicity to nervous cells, (ii) indicate that multiple cell death pathways can be induced, (iii) show that apoptosis is the main death pathway, (iv) demonstrate the involvement of necroptosis and (v) oxidative stress.

Keywords: Anti-cancer drug; Apoptosis; Neuroblastoma; Oxidative stress; Plant toxin; Ribosome-inactivating protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology
  • Apoptosis / drug effects*
  • Caspase Inhibitors / pharmacology*
  • Caspases / metabolism
  • Catalase / pharmacology*
  • Cell Death / drug effects
  • Cell Line, Tumor / drug effects
  • Humans
  • Imidazoles / pharmacology*
  • Indoles / pharmacology*
  • Lectins / adverse effects*
  • N-Glycosyl Hydrolases / adverse effects*
  • Neuroblastoma / pathology*
  • Oxidative Stress
  • Reactive Oxygen Species / metabolism

Substances

  • Amino Acid Chloromethyl Ketones
  • Caspase Inhibitors
  • Imidazoles
  • Indoles
  • Lectins
  • Reactive Oxygen Species
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • necrostatin-1
  • Catalase
  • N-Glycosyl Hydrolases
  • stenodactylin protein, Adenia stenodactyla
  • Caspases